2025-04-08 18:32:32
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Lincoln Pharmaceuticals Ltd consolidated Q2FY22 PAT climbs to Rs. 23.02 crore
Posted On : 2021-11-11 21:01:08( TIMEZONE : IST )
Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 130.9281 crores during the period ended September 30, 2021 as compared to Rs. 124.1995 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 23.0245 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 17.6982 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 11.51 for the period ended September 30, 2021 as compared to Rs. 8.85 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 130.9281 crs | ₹124.1995 crs |  5.42% |
| Net Profit | ₹23.0245 crs | ₹17.6982 crs | 30.10% |
| EPS | ₹11.51 | ₹8.85 | 30.06% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 130.9281 crores during the period ended September 30, 2021 as compared to Rs.126.6661 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.23.0245 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.20.9119 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.11.51 for the period ended September 30, 2021 as compared to Rs.10.46 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 130.9281 crs | ₹126.6661 crs | 3.36% |
| Net Profit | ₹23.0245 crs | ₹20.9119 crs | 10.10% |
| EPS | ₹11.51 | ₹10.46 | 10.04% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.255.1276 crores during the 6 Months period ended September 30, 2021 as compared to Rs.232.2577 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.40.7228 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.36.1693 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.20.36 for the 6 Months period ended September 30, 2021 as compared to Rs.18.08 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹255.1276 crs | ₹232.2577 crs | 9.85% |
| Net Profit | ₹40.7228 crs | ₹36.1693 crs | 12.59% |
| EPS | ₹20.36 | ₹18.08 | 12.61% |
Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 345.60 as compared to the previous close of Rs. 349.70. The total number of shares traded during the day was 32054 in over 1809 trades.
The stock hit an intraday high of Rs. 351.25 and intraday low of 342.70. The net turnover during the day was Rs. 11152513.00.
